CORMEDIX INC. Shareholders' Equity
CORMEDIX INC. (CRMD) had Shareholders' Equity of $460.83 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $460.83M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $437.05M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $405.31M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $374.13M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $460.83M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $437.05M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $405.31M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $374.13M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $220.63M 10-Q · filed 2026-08-13 | $220.63M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $114.89M 10-Q · filed 2026-08-13 | $114.89M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $84.66M 10-Q · filed 2026-08-13 | $84.66M 10-K · filed 2025-03-25 |
| 2024-09-30 | $58.71M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $46.18M 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $58.01M 10-Q · filed 2025-08-07 | |
| 2023-12-31 | $70.14M 10-K · filed 2026-03-05 | $70.14M 10-K · filed 2024-03-12 |
| 2023-09-30 | $83.20M 10-Q · filed 2024-10-30 | |
| 2023-06-30 | $49.05M 10-Q · filed 2024-10-30 | |
| 2023-03-31 | $53.93M 10-Q · filed 2024-08-14 | |
| 2022-12-31 | $55.06M 10-K · filed 2025-03-25 | |
| 2022-09-30 | $56.31M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $61.74M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $59.87M 10-Q · filed 2023-08-08 | |
| 2021-12-31 | $62.80M 10-K · filed 2024-03-12 | |
| 2021-09-30 | $69.34M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $76.87M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $80.32M 10-Q · filed 2022-08-11 | |
| 2020-12-31 | $44.22M 10-K · filed 2023-03-30 | |
| 2020-09-30 | $34.47M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $18.52M 10-Q · filed 2020-11-05 | |
| 2020-03-31 | $21.59M 10-Q · filed 2021-05-13 | |
| 2019-12-31 | $23.65M 10-K · filed 2022-03-29 | |
| 2019-09-30 | $28.71M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $16.48M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $16.54M 10-Q · filed 2020-08-10 | |
| 2018-12-31 | $4.93M 10-K · filed 2021-03-30 | $4.93M 10-Q · filed 2019-05-13 |
| 2018-09-30 | -$9.50M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | -$6.48M 10-Q · filed 2019-11-14 | |
| 2018-03-31 | $840.69K 10-Q · filed 2019-08-14 | |
| 2017-12-31 | $7.19M 10-K · filed 2020-03-16 | |
| 2017-09-30 | $9.68M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $15.37M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $11.04M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $17.81M 10-K · filed 2019-05-29 | |
| 2016-09-30 | $23.78M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $28.07M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $30.52M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $34.01M 10-K · filed 2018-03-19 | |
| 2015-09-30 | $36.39M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $36.85M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $7.60M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $3.63M 10-K · filed 2017-03-16 | |
| 2014-09-30 | $5.58M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | -$1.60M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | -$3.73M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | -$4.02M 10-K · filed 2017-03-16 | |
| 2013-09-30 | -$2.74M 10-Q/A · filed 2014-03-04 | -$2.91M 10-Q · filed 2013-11-19 |
| 2013-06-30 | -$2.03M 10-Q/A · filed 2014-03-04 | -$2.19M 10-Q · filed 2013-08-14 |
| 2013-03-31 | -$1.13M 10-Q/A · filed 2014-03-04 | -$1.28M 10-Q · filed 2013-05-15 |
| 2012-12-31 | -$335.38K 10-K · filed 2015-03-12 | -$475.38K 10-K · filed 2013-03-27 |
| 2012-09-30 | -$441.82K 10-Q/A · filed 2013-03-27 | -$116.82K 10-Q · filed 2012-11-13 |
| 2012-06-30 | -$143.48K 10-Q/A · filed 2012-09-06 | |
| 2012-03-31 | $423.03K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $1.33M 10-K/A · filed 2014-03-04 | $1.24M 10-K · filed 2012-03-19 |
| 2011-09-30 | $737.84K 10-Q · filed 2011-11-10 | |
| 2011-06-30 | $3.23M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $7.26M 10-K · filed 2013-03-27 | |
| 2009-12-31 | -$14.71M 10-K · filed 2013-03-27 | |
| 2008-12-31 | -$12.03M 10-K · filed 2013-03-27 | |
| 2007-12-31 | -$4.40M 10-K · filed 2013-03-27 | |
| 2006-12-31 | -$966.17K 10-K · filed 2013-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |